8-(Tosylamino)quinoline inhibits macrophage-mediated inflammation by suppressing NF-κB signaling

Yongwoo Jung1, Se Eun Byeon, Dae Sung Yoo

  • 1Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea.

Abstract

Insights

8-(tosylamino)quinoline (8-TQ) significantly suppresses macrophage inflammation by inhibiting the Akt/NF-κB pathway. This novel compound shows potential as an anti-inflammatory drug for various diseases.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Macrophage-mediated inflammation is implicated in diseases like cancer, diabetes, atherosclerosis, and septic shock.
  • Identifying novel compounds to modulate inflammatory responses is crucial for therapeutic development.

Purpose of the Study:

  • To characterize new compounds for their ability to suppress macrophage-mediated inflammation.
  • To investigate the underlying mechanisms of anti-inflammatory activity.

Main Methods:

  • Assessed anti-inflammatory activity in lipopolysaccharide (LPS)-activated RAW264.7 cells and mouse peritoneal macrophages.
  • Investigated mechanisms by measuring transcription factor activation and kinase activities.
  • Evaluated in vivo efficacy in LPS-induced hepatitis and HCl/EtOH-induced gastritis mouse models.

Main Results:

  • 8-(tosylamino)quinoline (8-TQ) demonstrated potent suppression of nitric oxide, TNF-α, and PGE(2) production (IC(50)=1-5 μmol/L).
  • 8-TQ dose-dependently inhibited pro-inflammatory gene expression (iNOS, COX-2, TNF-α, IL-1β, IL-6) at the transcriptional level.
  • 8-TQ suppressed Akt and NF-κB activation, along with upstream signaling molecules IκBα and IKK.
  • In vivo, 8-TQ alleviated LPS-induced hepatitis and gastritis symptoms.

Conclusions:

  • 8-TQ exhibits significant anti-inflammatory effects via Akt/NF-κB pathway inhibition.
  • 8-TQ demonstrates therapeutic potential as a novel anti-inflammatory agent.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...